In CRC, NK cells effectively eliminate CRC stem cells and cancer-initiating cells, which express lower levels of class I major histocompatibility complex (MHC) but high levels of ligands that bind the natural cytotoxicity activating receptors (NCR) NKp30 and NKp44. This evidence concerns the gene HLA-C and colorectal carcinoma.